Sanger Sequencing reactions through genewiz (ongoing)

AZENTA US, INC. has been awarded contract A207_PO-0352875-V3 by the University of Virginia, effective August 15, 2026. The University of Virginia, located in Virginia, serves as the contracting organization for this procurement action. AZENTA US, INC. is designated as the prime contractor responsible for fulfilling all contractual obligations under this agreement.

The contract encompasses the provision of Sanger Sequencing reactions through Genewiz on an ongoing basis. The line item specification indicates a unit of measure denominated in individual reactions, with the deliverable location designated as the Buyer. The contract is structured on a per-unit pricing model; however, the specific unit price, total contract amount, cumulative value, and period of performance are not detailed in the materials provided. The nature of the requirement as "ongoing" suggests this represents a requirements-based or indefinite delivery arrangement for molecular biology sequencing services.